Study authors sought to characterize the tolerance test, and HbA1c—in a population of patients with coronary artery disease (CAD).
Read More »Production Assistant, Diabetes In Control
Use of SGLT-2 inhibitors As Adjunct to Insulin In People with Type 1 Diabetes
Apart from Sotagliflozin’s use in the treatment of people with type 2, SGLT-1 and SGLT-2 inhibitors effects on type 1 currently being explored.
Read More »Osteoporosis and Diabetes: Pros and Cons to Antidiabetic Regimens
Study aims to distinguish different antidiabetic drugs and their effect on osteoporosis in people with diabetes.
Read More »Reducing Insulin Use and Improving Glycemic Control Via Single Dose of Glucagon-Blocking Drug
People with type 1 diabetes receiving once-daily injection of glucagon-blocking drug, REMD-477 can reduce their insulin use considerably and improve blood glucose levels without altering hypoglycemia.
Read More »Unlikely Outcomes in Elderly Patients Using Polypharmacy
Older adults taking five or more drugs are likely to exhibit negative side effects.
Read More »Additional Testing
Which additional test do you prefer to use when doing a physical exam? 1. A fasting blood glucose 2. An A1c 3. Neither Follow the link to share your opinion!
Read More »Optimal BP for a Person with Type 2 Diabetes and Kidney Disease
A 62-year-old man presents with type 2 diabetes, hypertension, and albuminuria. His seated BP is 162/104 mm Hg. What's an ideal blood pressure target for this patient? A. 140/90 mm Hg B. 130/80 mm Hg C. 120/70 mm Hg D. 150/80 mm Hg Follow the link to see the correct answer.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #81: Insulin Actions In Vivo: Glucose Metabolism Part 7 of 9
Cellular, biochemical, and molecular mechanisms of insulin action: The insulin receptor is a glycoprotein consisting of two alpha subunits and two beta subunits linked by disulfide bonds and expresses insulin-stimulated kinase activity directed towards its own tyrosine residues. Insulin receptor phosphorylation of the α subunit, with subsequent activation of insulin receptor tyrosine kinase, represents the first step in the action of insulin on glucose metabolism.
Read More »Glucose Self-Monitoring For Non-Insulin Using Patients Did Not Improve Control
The value of self-monitoring of blood glucose (SMBG) levels in patients with non-insulin-treated type 2 diabetes has been debated over the years.
Read More »ADA: Oral Insulin May Delay Type 1 Diabetes Onset
In adults with two or more antibodies predicting the development of type 1 diabetes, treatment with daily oral insulin therapy did not prevent development of the disease, but a small subset experienced a 31-month delay in clinical diabetes development.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.